BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38138250)

  • 21. When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer.
    Papadia A; Bellati F; Bogani G; Ditto A; Martinelli F; Lorusso D; Donfrancesco C; Gasparri ML; Raspagliesi F
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S944-51. PubMed ID: 26268452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer.
    Nagao S; Yamamoto K; Oishi T; Yamaguchi S; Takehara K; Shimada M; Kigawa J
    Int J Clin Oncol; 2021 Jan; 26(1):207-215. PubMed ID: 32960420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
    Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
    Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
    Kornovski Y; Gorchev G
    J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility-Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer.
    Zusterzeel PLM; Aarts JWM; Pol FJM; Ottevanger PB; van Ham MAPC
    Oncologist; 2020 Jul; 25(7):e1051-e1059. PubMed ID: 32339376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
    Rosa DD; Medeiros LR; Edelweiss MI; Bozzetti MC; Pohlmann PR; Stein AT; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005342. PubMed ID: 19588370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2).
    Akhavan S; Alibakhshi A; Parsapoor M; Alipour A; Rezayof E
    BMC Cancer; 2021 Jun; 21(1):667. PubMed ID: 34088300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
    Falcetta FS; Medeiros LR; Edelweiss MI; Pohlmann PR; Stein AT; Rosa DD
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD005342. PubMed ID: 27873308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
    Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
    Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant chemotherapy combined with radical surgery for stage IB2/IIA2 cervical squamous cell carcinoma: a prospective, randomized controlled study of 35 patients.
    Jing H; Xiuhong W; Ying Y; Zhenrong L; Xiyun C; Deping L; Changmei S; Qi W; Tao P; Yiyun P
    World J Surg Oncol; 2021 Jul; 19(1):209. PubMed ID: 34253208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage (2019) IB3/II cervical cancer.
    Chakrabarti M; Nordin A; Khodabocus J
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD012246. PubMed ID: 36111784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic versus robotic radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical cancer: a case control study.
    Vizza E; Corrado G; Mancini E; Vici P; Sergi D; Baiocco E; Patrizi L; Saltari M; Pomati G; Cutillo G
    Eur J Surg Oncol; 2015 Jan; 41(1):142-7. PubMed ID: 24063966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
    Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study.
    Höckel M; Wolf B; Schmidt K; Mende M; Aktas B; Kimmig R; Dornhöfer N; Horn LC
    Lancet Oncol; 2019 Sep; 20(9):1316-1326. PubMed ID: 31383547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study.
    Cibula D; Dostalek L; Hillemanns P; Scambia G; Jarkovsky J; Persson J; Raspagliesi F; Novak Z; Jaeger A; Capilna ME; Weinberger V; Klat J; Schmidt RL; Lopez A; Scibilia G; Pareja R; Kucukmetin A; Kreitner L; El-Balat A; Pereira GJR; Laufhütte S; Isla-Ortiz D; Toptas T; Gil-Ibanez B; Vergote I; Runnenbaum I
    Eur J Cancer; 2021 Jan; 143():88-100. PubMed ID: 33290995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.